Article ID Journal Published Year Pages File Type
1222160 Journal of Pharmaceutical and Biomedical Analysis 2012 10 Pages PDF
Abstract

A number of degradants of the antifungal agent posaconazole have been isolated and characterized. Degradation chemistry occurs primarily in the piperazine moiety located near the center of the molecule and typically involves oxidative processes. At least one ring contraction product has also been fully characterized by MS and NMR methods. We report the isolation and characterization of a novel degradant of posaconazole in which remnants of the piperazine ring have been incorporated into a 1,4-benzodiazepine moiety. The structure of the novel degradant was unequivocally established through accurate mass measurements, MS/MS studies, H/D exchange, and a range of 2D NMR experiments that included 1,1-ADEQUATE and covariance calculated HSQC-1,1-ADEQUATE spectra.

Related Topics
Physical Sciences and Engineering Chemistry Analytical Chemistry
Authors
, , , ,